Skip to main content
SpringerLink
Log in

Catechol-O-methyltransferase (COMT) Val158Met Polymorphism and Susceptibility to Alcohol Dependence

  • Review Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Catechol-O-methyl transferase (COMT) enzyme catalyzes the metabolism of dopamine and other catechols in the brain. Several articles investigated catechol-O-methyltransferase (COMT) Val158Met polymorphism as risk factor for alcohol dependence (AD) but the results were inconclusive. The aim of present meta-analysis was to evaluate the association of Val158Met (COMT) polymorphism with AD. Authors performed keyword search of the 4 electronic databases—Pubmed, Google Scholar, Springer Link and Science Direct databases up to December 31, 2019. Total eighteen studies that investigated the association of Val158Met polymorphism with AD were retrieved. The pooled results from the meta-analysis (2278 AD cases and 3717 healthy controls) did not show association with AD using all 5 genetic models (allele contrast model: OR = 1.02, 95% CI = 0.90–1.14, p = 0.03; homozygote model: OR = 1.06, 95% CI = 0.81–1.38, p = 0.69; dominant model: OR = 0.99, 95% CI = 0.85–1.14, p = 0.87; co-dominant model: OR = 0.97, 95% CI = 0.86–1.11, p = 0.71; recessive model: OR = 1.05;95% CI = 0.85–1.29, p = 0.61). Results of subgroup analysis showed that Val158Met is not risk for AD in Asian and Caucasian population. In conclusion, COMT Val158Met is not a risk factor for alcohol dependence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Koob GF. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res. 2003;27:232–43.

    CAS  PubMed  Google Scholar 

  2. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine’s role in drug abuse and addiction. Neuropharmacology. 2009;56:3–8.

    CAS  PubMed  Google Scholar 

  3. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: WHO; 2009.

    Google Scholar 

  4. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:830–42.

    PubMed  Google Scholar 

  5. Stacey D, Clarke TK, Schumann G. The genetics of alcoholism. Curr Psychiatry Rep. 2009;11:364–9.

    PubMed  Google Scholar 

  6. Bienvenu OJ, Davydow DS, Kendler KS. Psychiatric ‘diseases’ versus behavioral disorders and degree of genetic influence. Psychol Med. 2010;4:1–8.

    Google Scholar 

  7. Ducci F, Enoch MA, Funt S, Virkkunen M, Albaugh B, Goldman D. Increased anxiety and other similarities in temperament of alcoholics with and without antisocial personality disorder across three diverse populations. Alcohol. 2007;41:3–12.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci. 2006;29:565–98.

    CAS  PubMed  Google Scholar 

  9. Guldberg HC, Marsden CA. Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev. 1975;27:135–206.

    CAS  PubMed  Google Scholar 

  10. Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51:593–628.

    CAS  PubMed  Google Scholar 

  11. Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004;56:331–49.

    CAS  PubMed  Google Scholar 

  12. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci. 2002;22:389–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Yavich L, Forsberg M, Gogos JA, Karayiorgou M, Mannisto PT. Site specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci. 2007;27:10196–202.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. Kinetics of human soluble and membraneboundcatechol O-methyltransferase: a revised mechanism anddescription of the thermolabile variant of the enzyme. Biochemistry. 1995;34:4202–10.

    CAS  PubMed  Google Scholar 

  15. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF. Association of codon 108/158catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet. 1996;67:468–72.

    CAS  PubMed  Google Scholar 

  16. Kumar P, Yadav U, Rai V. Prevalence of COMT Val158Met polymorphism in Eastern UP population. Cell Mol Biol. 2017;63(6):21–4.

    CAS  PubMed  Google Scholar 

  17. Nobile M, Rusconi M, Bellina M, Marino C, Giorda R, Carlet O, Vanzin L, Molteni M, Battaglia M. COMT Val158Met polymorphism and socioeconomic status interact to predict attention deficit/hyperactivity problems in children aged 10–14. Eur Child Adolesc Psychiatry. 2010;19:549–57.

    PubMed  Google Scholar 

  18. Spielman RS, Weinshilboum RM. Genetics of red cell COMT activity: analysis of thermal stability and family data. Am J Med Genet. 1981;10:279–90.

    CAS  PubMed  Google Scholar 

  19. Chen CH, Lee YR, We FC, Koong FJ, Hwu HG, Hsiao KJ. Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry. 1997;41:985–7.

    CAS  PubMed  Google Scholar 

  20. Gadow KD, Roohi J, DeVincent CJ, Kirsch S, Hatchwell E. Association of COMT (Val158Met) and BDNF (Val66Met) gene polymorphisms with anxiety, ADHD and tics in childrenwith autism spectrum disorder. J Autism Dev Disord. 2009;39:1542–51.

    PubMed  PubMed Central  Google Scholar 

  21. Ohara K, Nagai M, Suzuki Y, Ohara K. Low activityallele of catechol-O-methyltransferase gene and Japaneseunipolar depression. Neuroreport. 1998;9:1305–8.

    CAS  PubMed  Google Scholar 

  22. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA. 1997;94:4572–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Retz W, Reosler M, Kissling C, Wiemann S, Hunnerkopf R, Coogan A, Thome J, Freitag C. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults. J Neural Transm. 2008;115:323–9.

    CAS  PubMed  Google Scholar 

  24. Valente NLM, Vallada H, Cordeiro Q, Bressan RA, Andreoli SB, Mari JJ, Mello MF. Catechol-O-methyltransferase (COMT) val158met polymorphism as a risk factor for PTSD after Urban Violence. J Mol Neurosci. 2011;43:516–23.

    CAS  PubMed  Google Scholar 

  25. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM. High activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet. 1997;74:439–42.

    CAS  PubMed  Google Scholar 

  26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting—meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.

    CAS  Google Scholar 

  27. Rai V, Yadav U, Kumar P, Yadav SK, Mishra OP. Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: a meta-analysis from 34 studies. PLoS ONE. 2014;9(9):e108552.

    PubMed  PubMed Central  Google Scholar 

  28. Higgins JP, Thompson SE. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    PubMed  Google Scholar 

  29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controll Clin Trials. 1986;7:177–88.

    CAS  Google Scholar 

  31. Egger M, Dave Smith G, Schneider M, Minde C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2012;6:50.

    Google Scholar 

  33. Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2013;49:1–5.

    Google Scholar 

  34. Ishiguro H, Haruo ST, Toru M, Saito T, Arinami T. Association study between high and low activity polymorphism of catechol-O-methyl transferase gene and alcoholism. Psychiatr Genet. 1999;9:135–8.

    CAS  PubMed  Google Scholar 

  35. Tiihonen J, Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynanen OP, Koulu M, Karvonen MK, Pohjalainen T, Syvalahti E, Hietala J. Association between the functional variant of the catechol-Omethyltransferase (COMT) gene and type 1 alcoholism. Mol Psychiatry. 1999;4:286–9.

    CAS  PubMed  Google Scholar 

  36. Hallikainen T, Lachman H, Saito T, Volavka J, Kauhanen J, Salonen JT, Ryynanen OP, Koulu M, Karvonen MK, Pohjalainen T, Syvalahti E, Hietala J, Tiihonen J. Lack of association between the functional variant of the catechol-O-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior. Am J Med Genet. 2000;96:348–52.

    CAS  PubMed  Google Scholar 

  37. Nakamura A, Inada T, Kita Y, Katayama Y. Association between catechol-O-methyltransferase (COMT) polymorphism and severe alcoholic withdrawal symptoms in male Japanese alcoholics. Addict Biol. 2001;6:233–8.

    CAS  PubMed  Google Scholar 

  38. Kohnke MD, Wiatr G, Kolb W, Kohnke AM, Schick S, Lutz U, Vonthein R, Gaertner I. Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. Neuropsychopharmacology. 2003;28:1004–10.

    PubMed  Google Scholar 

  39. Kweon YS, Lee HK, Lee CT. Pae CU (2005) Association study of catechol-O-methyltransferase gene polymorphism in Korean male alcoholics. Psychiatr Genet. 2015;15:151–4.

    Google Scholar 

  40. Enoch MA. Genetic and environmental influences on the development of alcoholism: resilience vs. risk. Ann N Y Acad Sci. 2006;1094:193–201.

    PubMed  Google Scholar 

  41. Sery L. Alcoholism and suicidal behaviour: a clinical overview. Acta Psychiatr Scand. 2006;113:13–22.

    Google Scholar 

  42. Voisey J, Swagell CD, Hughes IP, Lawford BR, Ross MD, Young RMD, Morris CP. A novel SNP in COMT is associated with alcohol dependence but not opiate or nicotine dependence: a case control study. Behav Brain Funct. 2011;7:51.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Wang T, Franke P, Neidt H, Cichon S, Knapp M, Lichtermann D, Maier W, Propping P, Nothen MM. Association study of the low-activity allele of catechol-O-methyl transferase and alcoholism using a family based approach. Mol Psychiatry. 2001;6:109–11.

    CAS  PubMed  Google Scholar 

  44. Altintoprak AE, Kayahan B, Kaymaz BT, Tezkanli B, Kosova B, Coskunol H. Catechol-O-methyltransferase Val108/158Met gene and alcoholism in Turkish subjects. Turk J Med Sci. 2012;42:289–97.

    CAS  Google Scholar 

  45. Schellekens AF, Franke B, Ellenbroek B, Cools A, de Jong CA, Buitelaar JK, Verkes RJ. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes. Arch Gen Psychiatry. 2012;69:339–48.

    CAS  PubMed  Google Scholar 

  46. Soyka M, Zill P, Koller G, Samochowiec A, Grzywacz A, Preuss UW. Val158Met COMT polymorphism and risk of aggression in alcohol dependence. Addict Biol. 2013;20:197–204.

    PubMed  Google Scholar 

  47. Malhotra S, Basu D, Khullar M, Ghosh A, Chugh N. Candidate genes for alcohol dependence: a genetic association study from India. Indian J Med Res. 2016;144(5):689–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Carrà G, Johnson S, Crocamo C, Angermeyer MC, Brugha T, Azorin JM, Bebbington PE. Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe. Psychiatry Res. 2017;239:301–7.

    Google Scholar 

  49. Samochowiec J, Kucharska-Mazur J, Grzywacz A, Jabłonski M, Rommelspacher H, Samochowiec A, Sznabowicz M, Horodnicki J, Sagan L, Pełka-Wysiecka J. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci Lett. 2006;410:1–5.

    CAS  PubMed  Google Scholar 

  50. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet. 2003;361:567–71.

    PubMed  Google Scholar 

  51. Rai V. Polymorphism in folate metabolic pathway gene as maternal risk factor for down syndrome. Int J Biol Med Res. 2011;2(4):1055–60.

    Google Scholar 

  52. Rai V, Kumar P. Fetal MTHFR C677T polymorphism confers no susceptibility to down syndrome: evidence from meta-analysis. Egypt J Med Hum Genet. 2018a;2018(19):53–8.

    Google Scholar 

  53. Rai V, Yadva U, Kumar P. Null association of maternal MTHFR A1298C polymorphism with Down syndrome pregnancy: an updated meta-analysis. The Egypt J Med Hum Genet. 2017;18(1):9–18.

    Google Scholar 

  54. Rai V. Maternal methylenetetrahydrofolate reductase (MTHFR) gene A1298C polymorphism and risk of nonsyndromic Cleft lip and/or Palate (NSCL/P) in offspring: a meta-analysis. Asian J Med Sci. 2014a;6(1):16–21.

    Google Scholar 

  55. Rai V. Strong association of C677T polymorphism of methylenetetrahydrofolate reductase gene with nosyndromic cleft lip/palate (nsCL/P). Ind J Clin Biochem. 2017a;33:5–15.

    Google Scholar 

  56. Kumar P, Yadav U, Rai V. Prevalence of glucose 6-pohsphate dehydrogenase deficiency in India: an updated meta-analysis. Egypt J Med Hum Genet. 2016;17:295–302.

    Google Scholar 

  57. Rai V, Kumar P. Methylenetetrahydrofolate reductase C677T polymorphism and risk of male infertility in Asian population. Ind J Clin Biochem. 2017;32(3):253–60.

    CAS  Google Scholar 

  58. Yadav U, Kumar P, Gupta S, Rai V. Role of MTHFR C677T gene polymorphism in the susceptibility of schizophrenia: an updated meta-analysis. Asian J Psychiatry. 2016;20:41–51.

    Google Scholar 

  59. Rai V, Yadav U, Kumar P, Yadav SK, Gupta S. Methylenetetrahydrofolate Reductase A1298C genetic variant and risk of schizophrenia: an updated meta-analysis. Indian J Med Res. 2017;145(4):437–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Kumar P, Rai V. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis. Metab Brain Dis. 2020;35:242–51.

    Google Scholar 

  61. Rai V. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene and susceptibility to depression in Asian population: a systematic meta-analysis. Cell Mol Biol. 2014b;60(3):29–36.

    CAS  PubMed  Google Scholar 

  62. Rai V. Association of C677T polymorphism (rs1801133) in MTHFR gene with depression. Cell Mol Biol. 2017b;63(6):60–7.

    CAS  PubMed  Google Scholar 

  63. Rai V, Kumar P. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy. Neurol Sci. 2018b;39(12):2033–41.

    PubMed  Google Scholar 

  64. Rai V. Folate pathway gene methylenetetrahydrofolate reductase C677T polymorphism and Alzheimer disease risk in Asian population. Indian J Clin Biochem. 2016a;31(3):245–52.

    CAS  PubMed  Google Scholar 

  65. Rai V. Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and alzheimer disease risk: a meta-analysis. Mol Neurobiol. 2017c;2017(54):1173–86.

    Google Scholar 

  66. Kumar P, Rai V. MTHFR C677T polymorphism and risk of esophageal cancer: an updated meta-analysis. Egypt J Med Hum Genet. 2018a;19:273–84.

    Google Scholar 

  67. Yadav U, Kumar P, Rai V. Role of MTHFR A1298C gene polymorphism in the etiology of prostate cancer: a systematic review and updated meta-analysis. Egypt J Med Hum Genet. 2016;17(2):141–8.

    Google Scholar 

  68. Rai V, Yadav U, Kumar P. Impact of Catechol-O-Methyltransferase Val 158Met (rs4680) polymorphism on breast cancer susceptibility in asian population. Asian Pac J Cancer Prev. 2017;18(5):1243–50.

    PubMed  PubMed Central  Google Scholar 

  69. Yadav U, Kumar P, Rai V. NQO1 gene C609T polymorphism (dbSNP: rs1800566) and digestive tract cancer risk: a meta-analysis. Nutr Cancer. 2018;70:557–68.

    CAS  PubMed  Google Scholar 

  70. Rai V. Methylenetetrahydrofolate reductase Gene C677T polymorphism and its association with ovary cancer. J Health Med Inf. 2016b;7:3–9.

    Google Scholar 

  71. Kumar P, Singh G, Rai V. Evaluation of COMT Gene rs4680 polymorphism as a risk factor for endometrial cancer. Ind J Clin Biochem. 2020;35:63–71.

    CAS  Google Scholar 

  72. Kumar P, Rai V. Catechol-O-Methyltransferase Val158Met polymorphism and susceptibility to Uterine Leiomyoma. Jacobs J Gynecol Obstet. 2018b;5(1):043–7.

    Google Scholar 

  73. Yadav U, Kumar P, Gupta S, Rai V. Distribution of MTHFR C677T gene polymorphism in healthy North Indian population and an updated meta-analysis. Ind J Clin Biochem. 2017;32(4):399–410.

    CAS  Google Scholar 

  74. Yadav U, Kumar P, Rai V. Distribution of methionine synthase reductase (MTRR) gene A66G polymorphism in Indian population. Ind J Clin Biochem. 2019. https://doi.org/10.1007/s12291-019-00862-9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Human Molecular Genetics Laboratory, Department of Biotechnology, VBS Purvanchal University, Jaunpur, 222003, India

    Amrita Chaudhary, Pradeep Kumar & Vandana Rai

Authors
  1. Amrita Chaudhary
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pradeep Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vandana Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vandana Rai.

Ethics declarations

Conflict of interest

None.

Human and Animals Participants

Informed consent and Ethical Clearance is not required, as there was no human or animal involvent in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chaudhary, A., Kumar, P. & Rai, V. Catechol-O-methyltransferase (COMT) Val158Met Polymorphism and Susceptibility to Alcohol Dependence. Ind J Clin Biochem 36, 257–265 (2021). https://doi.org/10.1007/s12291-020-00933-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-020-00933-2

Keywords

Search

Navigation